P-B33 HPV Persistence and age-specific type distribution among Nigerian women

Different trends have been reported on the age prevalence of HPV in Africa. The results of some studies showed there was a high peak of HPV prevalence among younger women, which decreased with age, but among older women the prevalence either decreased, reached a plateau or increased. There is scare...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2016-01, Vol.71, p.1
Hauptverfasser: Adebamowo, Sally, Famooto, Ayo, Dareng, Eileen, Olawande, Toyosi, Olaniyan, Olayinka, Offiong, Richard, Adebamowo, Clement
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 1
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume 71
creator Adebamowo, Sally
Famooto, Ayo
Dareng, Eileen
Olawande, Toyosi
Olaniyan, Olayinka
Offiong, Richard
Adebamowo, Clement
description Different trends have been reported on the age prevalence of HPV in Africa. The results of some studies showed there was a high peak of HPV prevalence among younger women, which decreased with age, but among older women the prevalence either decreased, reached a plateau or increased. There is scare data on the relation between persistent HPV infection and age. Women presenting at cervical cancer screening programs in Abuja, Nigeria between 2012 and 2014 were enrolled, data on demographic characteristics, risk factors of HPV infection and samples of cervical exfoliated cells were collected at baseline, 6 and 12 months follow-up visits. DNA enzyme immunoassay (DEIA) and Roche Linear Array HPV Genotyping Test were used to characterize HPV. Persistent HPV infection was defined as positive results on 2 consecutive DEIA tests. We used logistic regression models to estimate the association between HIV and the risk of HPV infections. We enrolled 1020 women, their mean (SD) age was 37 (8), the prevalence of any HPV and persistent HPV was 53% and 17%, respectively. The women were dichotomized into age groups, young: 18-35 (42%) and older: >35 years (58%). The prevalence of any HPV infection was 47% among the young women and 53% among the older women, P-value = 0.004. The prevalence of persistent HPV infection was 44% among the young women and 56% among the older women, P-value = 0.67. The multivariate odds ratio (OR) and 95% confidence interval (95% CI) among the young women was 1.30 (95% CI: 0.85 to 1.16, P-value 0.06) for any HPV infection and 0.84 (95% CI: 0.58 to 1.21, P-value 0.35) for persistent HPV infection, compared to older women. These results suggest that the pattern of HPV persistence among young and older women is not different. We will present the results on type specific HPV infection stratified by age, at the upcoming meeting.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1760851252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3935319331</sourcerecordid><originalsourceid>FETCH-proquest_journals_17608512523</originalsourceid><addsrcrecordid>eNqNiksKwjAUAIMoWD93eOA60DRJP1tFcaN0IW5LbF9Lik1q0iLe3i48gKsZmJmRgGVC0CRNxXxyGUkqGJdLsvK-DUMWC5EF5JLTPedwzu-Qo_PaD2hKBGUqUA1S32Opa13C8OkRqik7_RgHbQ2ozpoGrrpBp5WBt-3QbMiiVk-P2x_XZHc63g5n2jv7GtEPRWtHZ6ZUsCQOU8kiGfH_ri_24j49</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760851252</pqid></control><display><type>article</type><title>P-B33 HPV Persistence and age-specific type distribution among Nigerian women</title><source>Ovid Lippincott Williams and Wilkins Journal Legacy Archive</source><source>Journals@Ovid Complete</source><source>Free E- Journals</source><creator>Adebamowo, Sally ; Famooto, Ayo ; Dareng, Eileen ; Olawande, Toyosi ; Olaniyan, Olayinka ; Offiong, Richard ; Adebamowo, Clement</creator><creatorcontrib>Adebamowo, Sally ; Famooto, Ayo ; Dareng, Eileen ; Olawande, Toyosi ; Olaniyan, Olayinka ; Offiong, Richard ; Adebamowo, Clement</creatorcontrib><description>Different trends have been reported on the age prevalence of HPV in Africa. The results of some studies showed there was a high peak of HPV prevalence among younger women, which decreased with age, but among older women the prevalence either decreased, reached a plateau or increased. There is scare data on the relation between persistent HPV infection and age. Women presenting at cervical cancer screening programs in Abuja, Nigeria between 2012 and 2014 were enrolled, data on demographic characteristics, risk factors of HPV infection and samples of cervical exfoliated cells were collected at baseline, 6 and 12 months follow-up visits. DNA enzyme immunoassay (DEIA) and Roche Linear Array HPV Genotyping Test were used to characterize HPV. Persistent HPV infection was defined as positive results on 2 consecutive DEIA tests. We used logistic regression models to estimate the association between HIV and the risk of HPV infections. We enrolled 1020 women, their mean (SD) age was 37 (8), the prevalence of any HPV and persistent HPV was 53% and 17%, respectively. The women were dichotomized into age groups, young: 18-35 (42%) and older: &gt;35 years (58%). The prevalence of any HPV infection was 47% among the young women and 53% among the older women, P-value = 0.004. The prevalence of persistent HPV infection was 44% among the young women and 56% among the older women, P-value = 0.67. The multivariate odds ratio (OR) and 95% confidence interval (95% CI) among the young women was 1.30 (95% CI: 0.85 to 1.16, P-value 0.06) for any HPV infection and 0.84 (95% CI: 0.58 to 1.21, P-value 0.35) for persistent HPV infection, compared to older women. These results suggest that the pattern of HPV persistence among young and older women is not different. We will present the results on type specific HPV infection stratified by age, at the upcoming meeting.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>Hagerstown: Lippincott Williams &amp; Wilkins Ovid Technologies</publisher><subject>Confidence intervals ; Deoxyribonucleic acid ; DNA ; Enzymes ; Human papillomavirus ; Risk factors ; Women</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2016-01, Vol.71, p.1</ispartof><rights>Copyright Lippincott Williams &amp; Wilkins Jan 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Adebamowo, Sally</creatorcontrib><creatorcontrib>Famooto, Ayo</creatorcontrib><creatorcontrib>Dareng, Eileen</creatorcontrib><creatorcontrib>Olawande, Toyosi</creatorcontrib><creatorcontrib>Olaniyan, Olayinka</creatorcontrib><creatorcontrib>Offiong, Richard</creatorcontrib><creatorcontrib>Adebamowo, Clement</creatorcontrib><title>P-B33 HPV Persistence and age-specific type distribution among Nigerian women</title><title>Journal of acquired immune deficiency syndromes (1999)</title><description>Different trends have been reported on the age prevalence of HPV in Africa. The results of some studies showed there was a high peak of HPV prevalence among younger women, which decreased with age, but among older women the prevalence either decreased, reached a plateau or increased. There is scare data on the relation between persistent HPV infection and age. Women presenting at cervical cancer screening programs in Abuja, Nigeria between 2012 and 2014 were enrolled, data on demographic characteristics, risk factors of HPV infection and samples of cervical exfoliated cells were collected at baseline, 6 and 12 months follow-up visits. DNA enzyme immunoassay (DEIA) and Roche Linear Array HPV Genotyping Test were used to characterize HPV. Persistent HPV infection was defined as positive results on 2 consecutive DEIA tests. We used logistic regression models to estimate the association between HIV and the risk of HPV infections. We enrolled 1020 women, their mean (SD) age was 37 (8), the prevalence of any HPV and persistent HPV was 53% and 17%, respectively. The women were dichotomized into age groups, young: 18-35 (42%) and older: &gt;35 years (58%). The prevalence of any HPV infection was 47% among the young women and 53% among the older women, P-value = 0.004. The prevalence of persistent HPV infection was 44% among the young women and 56% among the older women, P-value = 0.67. The multivariate odds ratio (OR) and 95% confidence interval (95% CI) among the young women was 1.30 (95% CI: 0.85 to 1.16, P-value 0.06) for any HPV infection and 0.84 (95% CI: 0.58 to 1.21, P-value 0.35) for persistent HPV infection, compared to older women. These results suggest that the pattern of HPV persistence among young and older women is not different. We will present the results on type specific HPV infection stratified by age, at the upcoming meeting.</description><subject>Confidence intervals</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Enzymes</subject><subject>Human papillomavirus</subject><subject>Risk factors</subject><subject>Women</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNiksKwjAUAIMoWD93eOA60DRJP1tFcaN0IW5LbF9Lik1q0iLe3i48gKsZmJmRgGVC0CRNxXxyGUkqGJdLsvK-DUMWC5EF5JLTPedwzu-Qo_PaD2hKBGUqUA1S32Opa13C8OkRqik7_RgHbQ2ozpoGrrpBp5WBt-3QbMiiVk-P2x_XZHc63g5n2jv7GtEPRWtHZ6ZUsCQOU8kiGfH_ri_24j49</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Adebamowo, Sally</creator><creator>Famooto, Ayo</creator><creator>Dareng, Eileen</creator><creator>Olawande, Toyosi</creator><creator>Olaniyan, Olayinka</creator><creator>Offiong, Richard</creator><creator>Adebamowo, Clement</creator><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20160101</creationdate><title>P-B33 HPV Persistence and age-specific type distribution among Nigerian women</title><author>Adebamowo, Sally ; Famooto, Ayo ; Dareng, Eileen ; Olawande, Toyosi ; Olaniyan, Olayinka ; Offiong, Richard ; Adebamowo, Clement</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_17608512523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Confidence intervals</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Enzymes</topic><topic>Human papillomavirus</topic><topic>Risk factors</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adebamowo, Sally</creatorcontrib><creatorcontrib>Famooto, Ayo</creatorcontrib><creatorcontrib>Dareng, Eileen</creatorcontrib><creatorcontrib>Olawande, Toyosi</creatorcontrib><creatorcontrib>Olaniyan, Olayinka</creatorcontrib><creatorcontrib>Offiong, Richard</creatorcontrib><creatorcontrib>Adebamowo, Clement</creatorcontrib><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adebamowo, Sally</au><au>Famooto, Ayo</au><au>Dareng, Eileen</au><au>Olawande, Toyosi</au><au>Olaniyan, Olayinka</au><au>Offiong, Richard</au><au>Adebamowo, Clement</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P-B33 HPV Persistence and age-specific type distribution among Nigerian women</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>71</volume><spage>1</spage><pages>1-</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>Different trends have been reported on the age prevalence of HPV in Africa. The results of some studies showed there was a high peak of HPV prevalence among younger women, which decreased with age, but among older women the prevalence either decreased, reached a plateau or increased. There is scare data on the relation between persistent HPV infection and age. Women presenting at cervical cancer screening programs in Abuja, Nigeria between 2012 and 2014 were enrolled, data on demographic characteristics, risk factors of HPV infection and samples of cervical exfoliated cells were collected at baseline, 6 and 12 months follow-up visits. DNA enzyme immunoassay (DEIA) and Roche Linear Array HPV Genotyping Test were used to characterize HPV. Persistent HPV infection was defined as positive results on 2 consecutive DEIA tests. We used logistic regression models to estimate the association between HIV and the risk of HPV infections. We enrolled 1020 women, their mean (SD) age was 37 (8), the prevalence of any HPV and persistent HPV was 53% and 17%, respectively. The women were dichotomized into age groups, young: 18-35 (42%) and older: &gt;35 years (58%). The prevalence of any HPV infection was 47% among the young women and 53% among the older women, P-value = 0.004. The prevalence of persistent HPV infection was 44% among the young women and 56% among the older women, P-value = 0.67. The multivariate odds ratio (OR) and 95% confidence interval (95% CI) among the young women was 1.30 (95% CI: 0.85 to 1.16, P-value 0.06) for any HPV infection and 0.84 (95% CI: 0.58 to 1.21, P-value 0.35) for persistent HPV infection, compared to older women. These results suggest that the pattern of HPV persistence among young and older women is not different. We will present the results on type specific HPV infection stratified by age, at the upcoming meeting.</abstract><cop>Hagerstown</cop><pub>Lippincott Williams &amp; Wilkins Ovid Technologies</pub></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2016-01, Vol.71, p.1
issn 1525-4135
1944-7884
language eng
recordid cdi_proquest_journals_1760851252
source Ovid Lippincott Williams and Wilkins Journal Legacy Archive; Journals@Ovid Complete; Free E- Journals
subjects Confidence intervals
Deoxyribonucleic acid
DNA
Enzymes
Human papillomavirus
Risk factors
Women
title P-B33 HPV Persistence and age-specific type distribution among Nigerian women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A14%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P-B33%20HPV%20Persistence%20and%20age-specific%20type%20distribution%20among%20Nigerian%20women&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Adebamowo,%20Sally&rft.date=2016-01-01&rft.volume=71&rft.spage=1&rft.pages=1-&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/&rft_dat=%3Cproquest%3E3935319331%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760851252&rft_id=info:pmid/&rfr_iscdi=true